RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex Disease

Stopped early · Phase 3 · Has a placebo group

Conditions studied: Pulmonary Mycobacterium Avium Complex Infection, Bronchiectasis, Lung Diseases

In brief

A 2-part multi-center, Phase 3, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of RHB-204 in adult subjects with underlying nodular bronchiectasis and documented MAC lung infection.

Key facts

Study ID
NCT04616924
Run by
RedHill Biopharma Limited
People needed
12
Starts
2020-12-01
Expected to finish
2023-08-28
Last updated by the study team
2025-03-18

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.